new drugs on the horizon for rheumatoid arthritis

There's lots of excitement about all the new drugs on the horizon for rheumatoid arthritis...Arava, Enbrel, Celebrex, Vioxx.

Arava (leflunomide) is a new disease-modifying antirheumatic drug. Hoechst is marketing it now in the U.S...later in Canada.

It's for first-line therapy...as an alternative to methotrexate, hydroxychloroquine, etc.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote